ŚWIĄTECZNA DARMOWA DOSTAWA od 20 grudnia do 8 stycznia! Zamówienia złożone w tym okresie wyślemy od 2 stycznia 2025. Sprawdź >
Dawkowanie wybranych leków stosowanych w celu doraźnego obniżenia ciśnienia tętniczego przedstawiono w tabeli 7.
Piśmiennictwo
1. Wytyczne Polskiego Towarzystwa Nadciśnienia Tętniczego. Nadciśnienie Tętnicze 2011; 15 (2): 55-82.
2. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet 2000; 356(9227): 411-417.
3. Burke RE, Dorfman M. Is emergent anti-hypertensive treatment beneficial in intracranial hemorrhage? J Emerg Med 2005; 29(1): 9-13.
4. Zanad F, Mebazaa A. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study. Eur J Heart Fail 2006; 697-705.
5. Narotam PK, Puri V. Management of hypertensive emergencies in acute brain disease: evaluation of the treatment effects of intravenous nicardipine on cerebral oxygenation. J Neurosurgery 2008; 109(6): 1065-1074.
6. Goldberg ME, Weaver FA. Strategies for managing perioperative hypertension. Crit Care Clin 2007; 23 (suppl 1): 7-21.
7. Perez MI, Musini VM. Pharmacological interventions for hypertensive emergencies: a Cochrane systemic review. J Hum Hypertens 2008; 22(9): 596-607.
8. Rhoney D, Peacock WF. Intravenous therapy for hypertensive emergencies, part 1. Am J Health Syst Pharm. 2009; 66(15): 1343-1352.
9. Rhoney D, Peacock WF. Intravenous therapy for hypertensive emergencies, part 1. Am J Health Syst Pharm 2009; 15 (66): 1448-1457.
10. De Gaudio AR, Chelazzi C, Villa G. Acute severe arterial hypertension: therapeutic options. Curr Drug Targets 2009; 10(8): 788-798.
11. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28: 1462-1536.
12. Januszewicz A, Januszewicz W, Szczepańska-Sadowska E, et al. Nadciśnienie tętnicze. Medycyna Praktyczna. Kraków 2007.
13. Papadopoulos DP, Mourouzis I, Thomopoulos C. Hypertension crisis. Blood Press 2010; 19 (6): 328-336.
14. Intercollegiate Stroke Working Party National clinical guidelines for stroke: second edition 2004.
15. Rosei EA, Salvetti M, Farsang C. European Society of Hypertension Scientific Newsletter: treatment of hypertensive urgencies and emergencies. J Hypertens 2006; 24: 2482.
16. Ringleb PA, Bousser MG, Ford G. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. The European Stroke Organization (ESO). Cerebrovasc Dis 2008; 25: 457-507.
17. Bergese SD, Puente EG. Clevidipine butyrate: a promising new drug for the management of acute hypertension. Expert Opin Pharmacother 2010; 11(2): 281-295.
18. Metra M, Teerlink JR, Voors AA. Vasodilators in the treatment of acute heart failure: what we know, what we don’t. Heart Fail Rev 2009; 14(4): 299-307.
19. Deeks ED, Keating GM, Kean SJ. Clevidipine: a review of its use in the management of acute hypertension. Am J Cardiovasc Drugs 2009; 9(2): 117-34.